Peter Leonard Grant

Celltran Ltd. develops cell therapy products for wound healing and skin regeneration. It develops polymer surface technology and methods for the culture of autologous and allogeneic cells. The company was founded in 2000 by Sheila MacNeil and Robert Short and is headquartered in Sheffield, UK.

Part of Dow, Inc., Chiros Ltd. is a chemical research and British development company. The company is based in Cambridge, UK.

Celsis International Ltd. develops and supplies medical diagnostic products and laboratory services. The company was founded by Sir Christopher Evans in 1992 and is headquartered in Westminster, the United Kingdom.

Fusion IP Ltd. operates as a holding company. It engages in the commercialization of intellectual properties that is developed at universities and similar establishments. The company was founded by Peter Leonard Grant, Stewart Gall and David Graham Baynes in 2002 and is headquartered in Sheffield, the United Kingdom.

Part of IP Group Plc, Fusion IP Sheffield Ltd. commercializes intellectual properties. The company is based in London, UK.

Progenteq Ltd. develops a novel cartiledge replacement therapy to revolutionize the treatment of acute knee injuries. The company was founded on November 29, 2009 and is headquartered in Cardiff, the United Kingdom.

PH Therapeutics Ltd. engages in the research and development of biological treatments. It develops novel antibody therapies to treat the orphan disease Pulmonary Arterial Hypertension. The company was founded in 2013 by Allan Lawrie and is headquartered in Leeds, the United Kingdom.

FaultCurrent Ltd. develops magnetic fault current limiter protection products. It offers passive magnetic fault current limiter (pmFCL), a Smart Grid technology that protects utility electrical distribution networks from unanticipated power surges and the new demands being placed on ageing and already overburdened electrical infrastructures from the connection of cleaner distributed energy sources. The company was founded by Jeremy Hall in 2012 and is headquartered in Caerphilly, the United Kingdom.

Phase Focus Ltd. provides optical prototype instruments. It brings to market a range of products and services based on its proprietary Phasefocus Virtual Lens- a disruptive technology that is revolutionising the performance of imaging instrumentation and bringing new user value to analytical applications from stain-free cell imaging and quantitative electron phase microscopy to ophthalmic lens metrology and beyond. The firm's Virtual Lens enables the observation and analysis of materials, processes and products in new ways and with unprecedented clarity and accuracy. The company was founded in 2006 and is headquartered in Sheffield, the United Kingdom.

Alesi Surgical Ltd. is a holding company, which engages in the manufacture and development of medical devices. It focuses on minimally invasive surgery. Alesi works with surgeons to identify, resolve issues and develops techniques for the healthcare provider. Its Ultravision is a revolutionary new system that clears surgical smoke from the visual field and prevents its release into the operating theatre during laparoscopic surgery. The company was founded by Neil Warren in 2009 and is headquartered in Cardiff, the United Kingdom.

Part of IP Group Plc, Fusion IP Cardiff Ltd. engages in the commercialization of intellectual property. The company is based in London, UK. The British company was founded by Neil Warren.